Quantitative Assessment of Myocardial Blood Flow in Cardiac Sarcoidosis: A Potential Next Step in the Further Integration of FDG-PET in Imaging Management?

JACC Cardiovasc Imaging. 2017 Feb;10(2):168-170. doi: 10.1016/j.jcmg.2016.10.008. Epub 2017 Jan 18.

Authors

Panithaya Chareonthaitawee¹, John P Bois², Bernard J Gersh²

Affiliations

¹ Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: Chareonthaitawee.Panithaya@mayo.edu.
² Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

PMID: 28109927
DOI: 10.1016/j.jcmg.2016.10.008

No abstract available

Keywords: inflammation; myocardial blood flow; myocardial flow reserve; positron emission tomography; sarcoid disease.

Publication types

Editorial
Comment

MeSH terms

Cardiomyopathies
Fluorodeoxyglucose F18*
Humans
Positron-Emission Tomography*
Radiopharmaceuticals
Sarcoidosis

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18